Letter to Editor-response: placebo response rates

Bibliographic Details
Main Author: Bishal Gyawali
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023000299
_version_ 1828005236635074560
author Bishal Gyawali
author_facet Bishal Gyawali
author_sort Bishal Gyawali
collection DOAJ
first_indexed 2024-04-10T07:28:04Z
format Article
id doaj.art-d9cfaf835b19453d889e859df6959980
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-04-10T07:28:04Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-d9cfaf835b19453d889e859df69599802023-02-24T04:31:24ZengElsevierEClinicalMedicine2589-53702023-02-0156101852Letter to Editor-response: placebo response ratesBishal Gyawali0Department of Oncology, Queen's University, Kingston, Ontario, Canada; Cancer Centre of Southeastern Ontario, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Canada; Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, Canada; Cancer Research Institute, Queen's University, 10 Stuart Street, Kingston, Canada.http://www.sciencedirect.com/science/article/pii/S2589537023000299
spellingShingle Bishal Gyawali
Letter to Editor-response: placebo response rates
EClinicalMedicine
title Letter to Editor-response: placebo response rates
title_full Letter to Editor-response: placebo response rates
title_fullStr Letter to Editor-response: placebo response rates
title_full_unstemmed Letter to Editor-response: placebo response rates
title_short Letter to Editor-response: placebo response rates
title_sort letter to editor response placebo response rates
url http://www.sciencedirect.com/science/article/pii/S2589537023000299
work_keys_str_mv AT bishalgyawali lettertoeditorresponseplaceboresponserates